Necrotizing Fascitis: Clinical Trials

9 trials for Necrotizing Fascitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 2 not yet recruiting, 1 unknown. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Necrotizing Fascitis: new trials by email Literature Review of Necrotizing Fascitis trials Research Report on Necrotizing Fascitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
Echography - Necrotizing Fascitis, Cellulitis
Not yet recruitingUniversity Hospital, Lille742026-06-152026-05-14
Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections
Hyperbaric Oxygen Therapy - Necrotizing Fascitis
Not applicableNot yet recruitingCorewell Health West1602025-11-142025-09-12
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
Administration of indocyanine green (ICG) and fluorescence imaging - Necrotizing Fascitis
RecruitingEric R. Henderson4202025-09-262026-11-09
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
Cytal® Wound Matrix, MicroMatrix® - Necrotizing Fascitis, Necrotizing Soft Tissue Infection
Not applicableRecruitingBenjamin T. Miller502025-03-052026-10-21
VAC and Conventional Dressing in the Healing Process of Necrotizing Fasciitis
VAC - Necrotizing Fascitis
Not applicableUnknownAssiut University302023-06-012023-05-31
Compare Effects of Dressing With Honey and EUSOL
Honey, EUSOL - Necrotizing Fascitis, Wound Infection
Not applicableCompletedDow University of Health Sciences3262020-03-012022-11-15
FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
No Intervention: Observational Cohort - Necrotizing Fascitis, Fournier Gangrene
RecruitingUniversity of Cagliari3002020-01-012026-01-22
A Single-stage Bilayered Skin Reconstruction With Glyaderm®
Dermal subsitute Glyaderm + skin graft, Skin graft alone - Burns, Full Thickness Burn
Not applicableCompletedUniversity Hospital, Ghent822017-02-012024-02-08
Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
Hyperbaric oxygen therapy - Necrotizing Soft Tissue Infection, Necrotizing Fascitis
CompletedOle Hyldegaard2602013-02-012019-06-24

Narrower conditions

Fasciitis, Necrotizing (9)  ·  Fasciitis (2)  ·  Fournier Gangrene (2)  ·  Soft Tissue Infections (2)  ·  Bacterial Infections (1)  ·  Burns (1)  ·  Cellulitis (1)  ·  Disease (1)  ·  Gangrene (1)  ·  Gas Gangrene (1)  ·  Infections (1)  ·  Necrosis (1)  ·  Shock, Septic (1)  ·  Skin Diseases, Bacterial (1)  ·  Staphylococcal Infections (1)

Broader conditions

Musculoskeletal Diseases (9)  ·  Fasciitis (7)  ·  Infections (3)  ·  Bacterial Infections and Mycoses (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin Diseases, Infectious (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Urogenital Diseases (2)  ·  Bacterial Infections (1)  ·  Clostridium Infections (1)  ·  Connective Tissue Diseases (1)

Interventions

Hyperbaric Oxygenation (2)  ·  Eusol (1)  ·  High-Energy Shock Waves (1)  ·  Honey (1)  ·  Optical Imaging (1)  ·  Skin Transplantation (1)

Sponsors

Assiut University (1)  ·  Benjamin T. Miller (1)  ·  Corewell Health West (1)  ·  Dow University of Health Sciences (1)  ·  Eric R. Henderson (1)  ·  Ole Hyldegaard (1)  ·  University Hospital, Ghent (1)  ·  University Hospital, Lille (1)  ·  University of Cagliari (1)

Countries

United States (3)  ·  Belgium (1)  ·  Denmark (1)  ·  Egypt (1)  ·  France (1)  ·  Italy (1)  ·  Pakistan (1)

Top investigators

Adolfo Pisanu, MD (1)  ·  Ole Hyldegaard, MD, PhD (1)  ·  Peter V Polzik, MD (1)

Results publications

PMID 28982834

NIH funding

R01AI184513 (1)